Program Overview
This program is designed to provide corporate professionals with a comprehensive understanding of Competitive Intelligence (CI) and its application in product development. The course offers deep insights into gathering, analyzing, and leveraging competitive data to create innovative products, mitigate competitive risks, and improve decision-making. Through real-life examples, situational awareness, and interactive exercises, participants will learn to incorporate CI into their strategic product development processes and resolve actual market challenges.
Features
- Understand key competitive intelligence frameworks and tools relevant to pharma.
- Analyze competitor strategies, product pipelines, and market dynamics effectively.
- Apply CI insights to strategic decision-making and problem resolution.
- Navigate ethical and regulatory considerations in CI processes.
Target audiences
- Professionals from the pharmaceutical industry, including those in product development, regulatory affairs, R&D, marketing, and strategic planning.
Curriculum
- 6 Sections
- 31 Lessons
- 2 Days
Expand all sectionsCollapse all sections
- Introduction to Competitive Intelligence (CI)7
- 1.0Definition and importance of CI in pharma product development.
- 1.1Key CI frameworks: Porter’s Five Forces, SWOT analysis, PESTLE analysis.
- 1.2Importance of CI in product strategy.
- 1.3Case Study: Leveraging CI for market entry.
- 1.4Distinction between competitive intelligence, market research, and business intelligence.
- 1.5Regulatory and ethical considerations in CI (compliance with laws like GDPR and FDA regulations).
- 1.6Group discussion on challenges faced in gathering competitor data within the pharma sector.
- Competitive Landscapes Analysis6
- 2.0Mapping competitors and understanding their positioning.
- 2.1Sources of CI in pharma: Clinical trial databases, patents, regulatory submissions, and publications.
- 2.2Tools and software for data mining (e.g., Cortellis, PubMed, IQVIA).
- 2.3Deep dive into competitive benchmarking.
- 2.4Case study: How a leading pharma company used CI to launch a first-to-market drug.
- 2.5Interactive Simulation: Analyze a mock competitor’s product development pipeline using CI tools.
- Trends and Jargons in CI4
- Strategic Decision-Making with CI6
- 4.0Translating CI insights into actionable strategies.
- 4.1Product positioning, go/no-go decision-making, and risk mitigation strategies.
- 4.2Evaluating competitor strengths and weaknesses through CI metrics.
- 4.3Scenario planning and forecasting market dynamics.
- 4.4Case Study: Success stories of pharma firms leveraging CI for strategic wins.
- 4.5Interactive Exercise: Simulate a “war room” exercise, crafting a strategy to counter a competitor’s new product launch.
- CI Tools, Techniques, and Ethical Considerations5
- 5.0Advanced CI tools: Predictive analytics, patent landscaping, and pipeline intelligence.
- 5.1Techniques: Reverse engineering competitor tactics, leveraging open-source intelligence (OSINT).
- 5.2Ethical dilemmas in CI gathering and resolving grey areas.
- 5.3Case Study: A look into the implications of ethical violations in CI.
- 5.4Breakout session: Ethical dilemma resolution exercises.
- Competitive Intelligence as a Value Driver4
Instructor
